Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
Titel:
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
Auteur:
Cahn, Pedro Pozniak, Anton L Mingrone, Horacio Shuldyakov, Andrey Brites, Carlos Andrade-Villanueva, Jaime F Richmond, Gary Buendia, Carlos Beltran Fourie, Jan Ramgopal, Moti Hagins, Debbie Felizarta, Franco Madruga, Jose Reuter, Tania Newman, Tamara Small, Catherine B Lombaard, John Grinsztejn, Beatriz Dorey, David Underwood, Mark Griffith, Sandy Min, Sherene